Breedlove Robert Charles sold PHAT

November 3, 2025 · Form 4 insider transaction

Breedlove Robert Charles sold 524 shares of Phathom Pharmaceuticals, Inc. at $13.51 per share, a transaction worth $7.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
524
Price
$13.51
Total value
$7.1K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 3, 2025
Filing dateNovember 5, 2025
Shares owned after47,407
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.

View the original Form 4 on SEC EDGAR
Breedlove Robert Charles sold PHAT: November 3, 2025 | Insider Trading Screener